XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 206 $ 148
Marketable securities 803 351
Receivable from collaboration partners ($39 and $745 from a related party) 39 745
Prepaid and other current assets 19 18
Total current assets 1,067 1,262
Long-term marketable securities 129 182
Property and equipment, net 35 32
Other noncurrent assets ($2 and $ - from a related party) 114 116
Total assets 1,345 1,592
Current liabilities:    
Accounts payable 20 10
Deferred revenue ($97 and $97 to a related party) 97 102
Other current liabilities 76 54
Total current liabilities 193 166
Deferred revenue, noncurrent ($355 and $462 to a related party) 355 462
Other noncurrent liabilities 140 122
Commitments (Note 16)
Stockholders’ equity:    
Preferred stock, $0.0001 par value per share; 10.0 shares authorized; no shares issued and outstanding 0 0
Common stock and additional paid-in capital, $0.0001 par value per share; 400.0 shares authorized; 72.9 shares in 2022 and 70.8 shares in 2021 issued and outstanding 1,206 1,118
Accumulated deficit (542) (275)
Accumulated other comprehensive loss (7) (1)
Total stockholders’ equity 657 842
Total liabilities and stockholders’ equity $ 1,345 $ 1,592